Management of Subdural Hematoma in Patients on Warfarin

Introduction to Warfarin Resumption

Warfarin should be restarted no earlier than 7-10 days after the initial hemorrhage in patients with subdural hematoma (SDH) and stable repeat scans, if there is a high risk of thromboembolism, according to the American Heart Association guidelines 1

Patients with mechanical heart valves, atrial fibrillation with CHA₂DS₂-VASc score ≥4, recent venous thromboembolism, left ventricular or left atrial thrombus, or history of thromboembolism with prior anticoagulation interruption are considered high-risk and may require warfarin resumption 1
Determining if the patient has a high thrombotic risk indication is crucial, with factors including mechanical heart valve, nonvalvular AF with CHA₂DS₂-VASc score ≥4, recent VTE, left ventricular or left atrial thrombus, and history of thromboembolism with prior anticoagulation interruption, as outlined by the American College of Cardiology 2

For high-risk patients, wait at least 7-10 days after SDH onset before resuming warfarin, and confirm SDH stability or significant reduction on follow-up imaging 1
For patients with lower thrombotic risk, waiting 4-8 weeks after SDH onset or until complete SDH resolution on imaging may be safer 1
For patients with high thrombotic risk, waiting at least 3-4 weeks after SDH onset, confirming SDH resolution or significant reduction on follow-up imaging, and considering a heparin bridge with intravenous unfractionated heparin is recommended, as suggested by the American Stroke Association 1
For patients with moderate thrombotic risk, waiting 4-8 weeks after SDH onset, ensuring complete SDH resolution on imaging, and considering antiplatelet therapy instead of full anticoagulation may be appropriate, according to the American Stroke Association 1
For patients with low thrombotic risk, permanently discontinuing anticoagulation and considering antiplatelet therapy if needed for other indications is recommended, as outlined by the American College of Cardiology 2

Lobar SDHs may have a higher risk of recurrence with anticoagulation resumption compared to deep SDHs, and elderly patients with lobar hemorrhages may have worse outcomes with warfarin continuation, as reported by the American Stroke Association 3
Advanced age and CKD increase both bleeding and thrombotic risk, and presence of microbleeds on MRI, incomplete resolution of the SDH, history of falls or trauma, and uncontrolled hypertension are also important considerations, according to the American Heart Association 2, 1
Not accounting for drug interactions with CKD and overlooking patient-specific factors, such as functional status and fall risk, can also impact decision-making, as outlined by the American Heart Association 2, 1

Factors such as larger SDH size, residual SDH, and chronic kidney disease may increase the risk of recurrence, although no specific citation is provided for these factors.
For a patient with chronic kidney disease (CKD) and subacute symptomatic subdural hematoma (SDH), anticoagulation should be withheld for at least 4 weeks after the hemorrhage and then carefully restarted only if there is a compelling high thrombotic risk indication, as recommended by the American College of Cardiology 2, 4, 1

Immediate discontinuation of all anticoagulants and antiplatelets is necessary during the acute period, with reversal of warfarin effect using fresh frozen plasma or prothrombin complex concentrate and vitamin K immediately, and protamine sulfate for heparin-associated SDH reversal, according to guidelines from the American Heart Association 1
The minimum discontinuation period for any patient with SDH is 1-2 weeks, but for elderly patients with CKD, a longer period (at least 4 weeks) is warranted due to increased bleeding risk, as suggested by the American Stroke Association 4, 1
Weekly neurological assessments for the first month and follow-up imaging at 2-4 weeks before considering anticoagulation resumption are necessary, with maintenance of INR at the lower end of therapeutic range if anticoagulation is resumed, as suggested by the American Stroke Association 1
Resuming anticoagulation too early increases the risk of SDH recurrence, which carries significant mortality risk in elderly patients, and failing to consider alternative approaches, such as left atrial appendage closure or middle meningeal artery embolization, may be detrimental, according to the American College of Cardiology 2